to continue ICD therapy. On the other hand, patients with EF improvement deserve a fair discussion of whether the SCD risk warrants continuation of ICD therapy. Some patients with normalized… Click to show full abstract
to continue ICD therapy. On the other hand, patients with EF improvement deserve a fair discussion of whether the SCD risk warrants continuation of ICD therapy. Some patients with normalized or close ‐ to ‐ normal EF may not have sufficiently high risk of VT/VF to benefit from continued ICD therapy. Patients with nonischemic cardiomyopathy have a lower risk of SCD and may not benefit from ongoing ICD therapy if EF has improved. 12 On the other hand, patients with a prior myocardial scar may continue to benefit from ICD even if their EF is better. Despite the informative results from the present and prior studies
               
Click one of the above tabs to view related content.